Search
Immunologist Ming Li studies mechanisms of immune regulation, and their relevance to diseases including cancer.
The Romesser lab studies colorectal and anal cancer with a focus on using radiotherapy to treat disease.
The Baylies laboratory studies the mechanisms that form and maintain muscle both during normal development and in disease.
Cancer biologist Tuomas Tammela investigates cellular heterogeneity in lung and pancreatic cancers.
Biochemist and Bioengineer Kayvan Keshari explores changes in cancer metabolism to develop advanced imaging techniques and cancer therapeutics.
Physician-Scientist A. Ari Hakimi, MD studies genetic and metabolic mechanisms of immune response in kidney cancers.
Biomedical engineer Daniel Heller is Head of the Cancer Nanotechnology Laboratory, which invents disruptive technologies to revolutionize the diagnosis and treatment of cancer and allied diseases.
Arvin Dar’s lab develops chemical tools and probes to explore disease mechanisms and the structural biology of cancer targets.
Molecular Pharmacology Program Member David Scheinberg focuses on the discovery and development of novel, specific immunotherapeutic agents and targeted nanodevices for cancer therapy.
The Shah lab focuses on the major topics of cancer evolution, single cell genomics and transcriptomics, mutational processes and prediction of drug response.